A5004187445- Diabetes Treatment and Management
- Quantum optics and atomic interactions
- Diabetes Management and Research
- Metabolism, Diabetes, and Cancer
- Cold Atom Physics and Bose-Einstein Condensates
- Atomic and Subatomic Physics Research
- Antifungal resistance and susceptibility
- Nausea and vomiting management
- Random lasers and scattering media
- Quantum Information and Cryptography
- Nail Diseases and Treatments
- Pancreatic function and diabetes
- Cardiovascular Function and Risk Factors
- Pathogenesis and Treatment of Hiccups
- Medication Adherence and Compliance
- Blood Pressure and Hypertension Studies
- Anesthesia and Pain Management
- Heart Rate Variability and Autonomic Control
- Pharmaceutical Economics and Policy
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Photonic Crystals and Applications
- Heart rate and cardiovascular health
- Cholinesterase and Neurodegenerative Diseases
- Photonic and Optical Devices
- Parkinson's Disease Mechanisms and Treatments
Koneru Lakshmaiah Education Foundation
2025
Glenmark Pharmaceuticals (India)
2022-2024
Caritas Hospital
2024
Homi Bhabha National Institute
2024
Tata Memorial Hospital
2024
Sparsh Hospital
2024
Sarojini Naidu Medical College
2024
Nagpur Institute of Technology
2023-2024
Information Technology Laboratory
2020-2021
National Institute of Standards and Technology
2020
Abstract Aims: The study aimed at evaluating efficacy and safety of Remogliflozin etabonate Vildagliptin fixed dose combination (FDC) compared to currently approved FDC Empagliflozin Linagliptin. Methods: A randomized, double-dummy, double-blind, active-controlled, parallel-group, two-arm, multi-center was conducted 26 sites across India. Type-2 diabetes mellitus (T2DM) patients aged between 18-65 years on metformin ≥1500 mg were randomized receive either Etabonate (RV) or Linagliptin (EL)...
In this paper, we propose a novel technique for slow light experiments using electromagnetically induced transparency two-dimensional magneto optical trap (2D-MOT). A compact 2D-MOT design efficient quantum memory applications with adjustable depth (OD) is proposed. We estimated the OD our setup and found that group velocities as low 1.4 m/s can be attained. Our allows precise control optimization of such high storage efficiencies could also achieved. With design, it possible to obtain delay...
Abstract Background: Teneligliptin has shown better efficacy, tolerability and reduced associated complications in patients with type 2 diabetes mellitus (T2DM) chronic kidney disease (CKD). The aim of this study was to evaluate the effect on renal function glycemic control Indian T2DM CKD a real-world setting. Methodology: This retrospective, observational that included 377 from 4 sites across India. Details prescriptions laboratory investigations individual patient were recorded. Primary...
12070 Background: Although the reports suggest 15-25% cancer patients receiving highly- and moderately emetogenic chemotherapy (HEC MEC) experience nausea vomiting beyond day 5, majority of clinical trials focus on delayed induced (CINV) only during first 5 days treatment. Here we present a real world observational data with fixed combination IntraVenous (Fos)NEtupitant Palonosetron (IV NEPA) in preventing nausea/vomiting extended phase among HEC/MEC. Methods: An open label, single arm,...
We outline a proposal to realize Electromagnetically Induced Transparency (EIT) with the potential store Terahertz (THz) optical pulses in Cesium atoms. Such system, when experimentally realized, has make Quantum Communication possible THz signals.
In this paper, we describe a theoretical design for the realization of high capacity (bandwidth) atomic quantum memory based on wavelength division multiplexing and electromagnetically induced transparency in adjacently placed 87Rb vapour cells. Magnetic fields produced by Helmholtz coils are used to tailor energy levels cells hence storage various probe signals different wavelengths becomes possible. We give detailed description proposed experimental setup. have estimated very bandwidth 50...
In this paper, we present a theoretical proposal to realize Quantum Memory (QM) for storage of blue light pulses (420 nm) using Electromagnetically Induced Transparency (EIT). Three-level lambda-type EIT configuration system is solved in fully quantum mechanical approach. Storing has the potential application field underwater communication as it experiences less attenuation inside sea water. Our model works by exciting relevant transitions [Formula: see text]Rb atoms three-level...
Research in the Quantum Communications and Networking Project at National Institute of Standards Technology's (NIST) Information Technology Laboratory (ITL) focuses on developing quantum devices studying them for use communications networking applications. In this paper, we review parts our research introduce case development metrology tools testbeds network systems.
Introduction: Owing to pharmacokinetic challenges of itraconazole, super-bioavailable itraconazole (SB) was developed and recently approved in strengths 50mg 65mg. But comparative study lacking between these two glabrous tinea (dermatophytosis) management. Hence, this planned compare the efficacy both dermatophytosis. Methods: One hundred eligible patients were enrolled prospective, randomized, clinical during May-2022 September-2022 at tertiary hospital Ahmedabad adults. Efficacy safety...
Itraconazole follows non-linear pharmacokinetics and hence is recommended once daily, but in real-world practice, commonly prescribed as twice daily. Hence, this study aimed to evaluate the efficacy safety of super-bioavailable-itraconazole-130 mg (SB-130) conventional-itraconazole-200 (CITZ-200) daily compared with conventional-itraconazole-100 (CITZ-100) glabrous tinea.A total 261 eligible patients were enrolled prospective, randomized, clinical from December-2021 August-2022 at seven...
Background Chemotherapy-induced nausea and vomiting is a common unpleasant treatment-related side effect reported by cancer patients receiving chemotherapy. Akynzeo® or NEPA (NEtupitant + PAlonosetron) the first fixed combination of netupitant palonosetron that targets both critical pathways involved in emesis while providing convenient, single oral dose therapy. The current study aimed to assess effectiveness safety real-world setting India. Methodology This was an open-label, multicenter,...
Azelnidipine, a selective calcium channel blocker, effectively lowers blood pressure (BP) and heart rate (HR) in hypertensive patients, as demonstrated retrospective real-world evidence (RWE) study Indian patients.
Background: In patient of T2DM and HF, reduced ejection fraction (HFrEF) constitutes the majority HF cases, posing significant risk mortality. NYHA classification, recommended in global guidelines, independently predicts SGLT2i have shown to reduce incidence hospitalization for HF. Hence, this study was planned evaluate effectiveness Remogliflozin improving class patients with Methods: prospective, multicentre study, 250 HFrEF having Class I III, were enrolled. 125 allocated each (R)...
Background: Lobeglitazone, a novel TZD was recently approved in India for T2DM, has limited real-world data. This study assessed the effectiveness and safety of Lobeglitazone 0.5 mg once daily settings. Methods: Data captured from medical records patients after obtaining independent ethics committee approval 16 different sites across India. The primary outcome % change HbA1c at week 12. Secondary outcomes were changes fasting blood sugar (FBS), post-prandial (PPBS), lipid, liver renal...
Introduction & Objective: Fixed dose combination (FDC) of Teneligliptin 20 mg + Dapagliflozin 10 has been recently approved in India for treatment T2DM. Study was designed to compare effect FDC (Arm A) with Sitagliptin 100 B) Linagliptin 5 Empagliflozin 25 C) parameters derived from CGM Indian T2DM Results: Present interim analysis report 50 patients shows changes when compared as intergroup between mg, at end phase II non-significant (p>0.05). Significant improvement seen...
<title>Abstract</title> Purpose IV Akynzeo® (Intravenous fosNEtupitant + PAlonosetron) is the first fixed intravenous combination designed to target key pathways of emesis, allowing for convenient single-dose administration. This study aimed evaluate safety and efficacy in a real-world context India. Methods open-label, single-arm, multicentre, prospective phase trial assessed single dose I.V. prevention CINV patients receiving highly emetogenic/ moderately emetogenic chemotherapy (HEC/MEC)....
Abstract Aims The ICMR INDIAB-17 study revealed a diabetes prevalence of 11.4% in India, emphasizing the need for effective treatment glycemic control. A Phase IV was conducted to evaluate safety and efficacy Fixed Dose Combination (FDC) Remogliflozin, Metformin Vildagliptin (RMV) Type 2 Diabetes Mellitus (T2DM) patients uncontrolled on plus SGLT2 inhibitor or DPP4 dual therapy. Methods total 215 (mean age: 46.4 years; 64% male, 36% female) were enrolled across multiple centers India....